跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
!!Link opens in a new tab
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
查看斯高帕斯 (Scopus) 概要
楊 宗霖
助理教授
,
心臟血管內科
成員
,
臺北醫學大學臺北心臟醫學研究中心
主治醫師
,
臺北醫學大學附設醫院
https://orcid.org/0000-0003-2073-3407
電子郵件
tsunglin.yang
tmu.edu
tw
,
151017
h.tmu.edu
tw
h-index
126
引文
7
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2012
2025
每年研究成果
概覽
指紋
網路
研究成果
(24)
類似的個人檔案
(12)
指紋
查看啟用 Tsung-Lin Yang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Cardiovascular System
100%
Cohort Analysis
58%
Pulse Wave Velocity
37%
Influenza Vaccination
21%
Chronic Kidney Disease
20%
Atrial Fibrillation
20%
Pulse Rate
19%
Hazard Ratio
18%
Breast Cancer
18%
Colorectal Cancer
18%
Hepatocellular Carcinoma
18%
Artery Calcification
18%
Side Effect
18%
Chinese Herbal Medicine
18%
COVID-19
18%
Hypotension
18%
Tamoxifen
18%
Acute Coronary Syndrome
18%
Influenza Vaccine
18%
Myocardial Bridge
18%
Cancer Risk
18%
Liver Cancer
18%
Messenger RNA
18%
Side Effect
18%
Allopurinol
18%
Febuxostat
18%
Brain Ischemia
15%
Adverse Event
11%
Myocardial Infarction
11%
Cardiovascular Disease
11%
Coronary Artery Disease
10%
Cerebral Hemorrhage
9%
Decoction
9%
Neoplasm
8%
All Cause Mortality
7%
Acute Heart Infarction
7%
Survival Time
6%
Drug Therapy
6%
Blood Pressure
5%
Cardiac Side Effect
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
63%
Chronic Kidney Failure
39%
Influenza Vaccine
37%
Acute Heart Infarction
25%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
23%
Atrial Fibrillation
20%
Comorbidity
20%
Vaccination Policy
19%
End Stage Renal Disease
18%
Aconitum
18%
Colorectal Cancer
18%
Tamoxifen
18%
Breast Cancer
18%
Bilirubin
18%
Liver Cell Carcinoma
18%
Hypotension
18%
Heart Failure
18%
Liver Cancer
18%
Myocardial Bridging
18%
Allopurinol
18%
Febuxostat
18%
Treatment Group
14%
Heart Infarction
13%
Brain Ischemia
13%
All Cause Mortality
11%
Brain Hemorrhage
9%
Statin (Protein)
9%
Mortality Rate
8%
Hemodialysis
7%
Survival Time
6%
Dyslipidemia
6%
Neoplasm
6%
Disease Course
5%
Adverse Event
5%
Nursing and Health Professions
Acute Heart Infarction
25%
Tamoxifen
18%
Breast Cancer
18%
Health Outcomes
18%
Treatment Group
14%
Hazard Ratio
14%
Heart Infarction
11%
Brain Hemorrhage
9%
Confidence Interval
9%
All Cause Mortality
9%
National Health Insurance
7%
Brain Ischemia
7%
Cohort Analysis
7%
